Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIOCONAZOLE vs TISLELIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIOCONAZOLE vs TISLELIZUMAB: Safety Overview

Metric TIOCONAZOLE TISLELIZUMAB
Total FAERS Reports 1,434 4,996
Deaths Reported 14 114
Death Rate 1.0% 2.3%
Hospitalizations 19 2,586
Average Patient Age 43.6 yrs 62.9 yrs
% Female Patients 99.8% 26.5%
FDA Approval Date Feb 11, 1997 N/A
Manufacturer H E B BeOne Medicines USA, Inc.
Route VAGINAL INTRAVENOUS
Marketing Status Discontinued N/A